For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of CME Group Inc (NASDAQ: CME) closed at $276.98 in the last session, up 0.47% from day before closing price of $275.68. In other words, the price has increased by $0.47 from its previous closing price. On the day, 1.51 million shares were traded. CME stock price reached its highest trading level at $277.64 during the session, while it also had its lowest trading level at $274.65.
Ratios:
We take a closer look at CME’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 38.77 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.46. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.13.
On September 25, 2025, Citigroup Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $300. UBS Downgraded its Buy to Neutral on July 24, 2025, while the target price for the stock was maintained at $305.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 20 ’25 when Sammann Derek sold 7,200 shares for $275.67 per share. The transaction valued at 1,984,798 led to the insider holds 7,022 shares of the business.
Sammann Derek bought 7,200 shares of CME for $1,979,928 on Nov 20 ’25. On Nov 03 ’25, another insider, Ford Harold Eugene Jr., who serves as the Director of the company, sold 1,000 shares for $263.53 each. As a result, the insider received 263,530 and left with 1,091 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CME now has a Market Capitalization of 99878928384 and an Enterprise Value of 101078425600. As of this moment, CME’s Price-to-Earnings (P/E) ratio for their current fiscal year is 26.85, and their Forward P/E ratio for the next fiscal year is 23.83. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.19. For the stock, the TTM Price-to-Sale (P/S) ratio is 15.61 while its Price-to-Book (P/B) ratio in mrq is 3.54. Its current Enterprise Value per Revenue stands at 15.83 whereas that against EBITDA is 22.491.
Stock Price History:
The Beta on a monthly basis for CME is 0.28, which has changed by 0.16158938 over the last 52 weeks, in comparison to a change of 0.1177547 over the same period for the S&P500. Over the past 52 weeks, CME has reached a high of $290.79, while it has fallen to a 52-week low of $221.51. The 50-Day Moving Average of the stock is 2.80%, while the 200-Day Moving Average is calculated to be 2.97%.
Shares Statistics:
According to the various share statistics, CME traded on average about 1.95M shares per day over the past 3-months and 2379310 shares per day over the past 10 days. A total of 359.85M shares are outstanding, with a floating share count of 359.04M. Insiders hold about 0.45% of the company’s shares, while institutions hold 90.96% stake in the company. Shares short for CME as of 1763078400 were 5410273 with a Short Ratio of 2.10, compared to 1760486400 on 4493938. Therefore, it implies a Short% of Shares Outstanding of 5410273 and a Short% of Float of 1.5.
Dividends & Splits
The forward annual dividend rate for CME is 4.87, which was 4.9 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.01777423. The stock’s 5-year Average Dividend Yield is 3.46. . The current Payout Ratio is 107.52% for CME, which recently paid a dividend on 2025-09-09 with an ex-dividend date of 2025-12-12. Stock splits for the company last occurred on 2012-07-23 when the company split stock in a 5:1 ratio.
